Plasma Proneurotensin and Incidence of Diabetes, Cardiovascular Disease, Breast Cancer, and Mortality | Zendy

Olle Melander | Zendy; Alan S. Maisel | Zendy; Peter Almgren | Zendy; Jonas Manjer | Zendy; Mattias Belting | Zendy; Bo Hedblad | Zendy; Gunnar Engström | Zendy; Ute Kilger | Zendy; Peter M. Nilsson | Zendy; Andreas Bergmann | Zendy; Marju OrhoMelander | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Plasma Proneurotensin and Incidence of Diabetes, Cardiovascular Disease, Breast Cancer, and Mortality

Author(s) -

Olle Melander,

Alan S. Maisel,

Peter Almgren,

Jonas Manjer,

Mattias Belting,

Bo Hedblad,

Gunnar Engström,

Ute Kilger,

Peter M. Nilsson,

Andreas Bergmann,

Marju OrhoMelander

Publication year - 2012

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2012.12998

Subject(s) - medicine , breast cancer , diabetes mellitus , hazard ratio , disease , cancer , population , proportional hazards model , incidence (geometry) , oncology , endocrinology , confidence interval , physics , environmental health , optics

Neurotensin regulates both satiety and breast cancer growth in the experimental setting, but little is known about its role in the development of breast cancer or cardiometabolic disease in humans.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research